Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/13 → 30/05/15 |
A phase 3 randomised controlled study of Cabozantinib (XL184) vs Everolimus in subjects with metastatic renal cell carcinoma that has progressed after prior VEGFR tyrosine kinase inhibitor therapy
- Davis, Ian (Primary Chief Investigator (PCI))
Project: Research